Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, cilt.140, sa.1, ss.151-157, 2014 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 140 Sayı: 1
- Basım Tarihi: 2014
- Doi Numarası: 10.1007/s00432-013-1553-7
- Dergi Adı: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.151-157
- Erciyes Üniversitesi Adresli: Hayır
Özet
The development of brain metastases (BMs) was associated with poor prognosis in melanoma patients. Patients with BMs have a median survival of < 6 months. Melanoma is the third most common tumor to metastasize to the brain with a reported incidence of 10-40 %. Our aim was to identify factors predicting development of BMs and survival.